共 50 条
- [1] ARE THERE SPECIAL CONSIDERATIONS RELEVANT TO TRIALS OF BIOLOGIC AGENTS - COMMENTJOURNAL OF RHEUMATOLOGY, 1994, 21 : 48 - 48HUBSCHER, O
- [2] ARE THERE SPECIAL CONSIDERATIONS RELEVANT TO TRIALS OF BIOLOGIC AGENTS - COMMENTJOURNAL OF RHEUMATOLOGY, 1994, 21 : 49 - 49WOODCOCK, J
- [4] ARE THERE SPECIAL CONSIDERATIONS RELEVANT TO TRIALS OF BIOLOGIC AGENTSJOURNAL OF RHEUMATOLOGY, 1994, 21 : 41 - 45STRAND, V
- [5] Biologic agents in rheumatology: Safety considerationsRHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2006, 32 : 3 - 10Lee, Susan J.Kavanaugh, Arthur
- [6] The ethics of phase I trials of biologic agentsNature Clinical Practice Gastroenterology & Hepatology, 2008, 5 : 533 - 533Stephen B Hanauer
- [7] The ethics of phase I trials of biologic agentsNATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (10): : 533 - 533Hanauer, Stephen B.
- [8] Trials in special populations - CommentCURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (08): : 631 - 631Walson, PD
- [9] Trials in special populations - CommentCURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (08): : 565 - 566Connor, JD
- [10] Trials in special populations - CommentCURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (04): : 299 - 299Walson, PD